Sanofi Q4 Adjusted Earnings, Net Sales Increase; 2026 Guidance Issued

MT Newswires Live01-29

Sanofi (SNY) reported Q4 adjusted earnings Thursday of 1.53 euros ($1.83) per share, up from 1.31 euros a year earlier.

Analysts polled by FactSet expected 1.45 euros.

Net sales for the quarter ended Dec. 31 were 11.30 billion euros, up from 10.56 billion euros a year earlier.

Analysts surveyed by FactSet expected 11.62 billion euros.

For 2026, the drugmaker said it expects high single-digit percentage sales growth at constant exchange rates, with adjusted EPS expected to grow "slightly faster than sales."

The company also said it plans to execute a one billion euro share buyback in 2026.

Shares of the company were up 1% in recent premarket activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment